Triazole-containing hydrogels for time-dependent sustained drug release

Macromol Rapid Commun. 2014 Feb;35(4):442-6. doi: 10.1002/marc.201300585. Epub 2013 Sep 9.

Abstract

The purpose of this study is to develop novel triazole-containing hydrogels (TGs) as drug carrier and to investigate the sustained drug release accomplished by their time-dependent swelling behavior. The synthetic pathway of TGs includes: (1) DCC-coupling on hydroxyethyl methacrylate (HEMA) to prepare HEMA-alkyne (HA), (2) click-coupling to prepare a triazole-ring-containing monomer (TM), and (3) the synthesis of a series of TGs. The aggregation between triazole rings is found to be responsible for drug release controllability. Rhodamine 6G is studied as a model anticancer drug for release experiments. The effects of pH and temperature on the properties of sustained drug release are also studied.

Keywords: DMAEMA; anticancer; hydrogels; sustained release; triazole.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / chemistry
  • Antineoplastic Agents / chemistry
  • Click Chemistry
  • Drug Carriers / chemistry*
  • Hydrogels / chemistry*
  • Hydrogen-Ion Concentration
  • Methacrylates / chemistry
  • Rhodamines / chemistry
  • Temperature
  • Time Factors
  • Triazoles / chemistry*

Substances

  • Alkynes
  • Antineoplastic Agents
  • Drug Carriers
  • Hydrogels
  • Methacrylates
  • Rhodamines
  • Triazoles
  • rhodamine 6G